Variant report
Variant | nsv1009984 |
---|---|
Chromosome Location | chr1:188947107-189037864 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:186)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:189009261..189011290-chr1:189013451..189014951,2 | K562 | blood: | |
2 | chr1:188973723..188976058-chr1:189233583..189235147,2 | K562 | blood: | |
3 | chr1:189009261..189011290-chr1:189013451..189014951,2 | K562 | blood: | |
4 | chr1:188975384..188977741-chr1:188982777..188984574,2 | K562 | blood: | |
5 | chr1:188975384..188977741-chr1:188982777..188984574,2 | K562 | blood: | |
6 | chr1:189032912..189034690-chr1:189118689..189120245,2 | K562 | blood: | |
7 | chr1:189027854..189030529-chr1:189039062..189041811,2 | K562 | blood: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PLA2G4A-17 | chr1:189029259-189029349 | refGeneNc_416_NR_033922 |
2 | lnc-PLA2G4A-17 | chr1:189035554-189037410 | refGeneNc_416_NR_033922 |
3 | lnc-PLA2G4A-6 | chr1:189005849-189006393 | ENSG00000226486 |
4 | lnc-PLA2G4A-17 | chr1:188974191-188974263 | refGeneNc_416_NR_033922 |
5 | lnc-FAM5C-14 | chr1:189005092-189005575 | NONHSAT008482 |
6 | lnc-PLA2G4A-17 | chr1:189027267-189027316 | refGeneNc_416_NR_033922 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CLPTM1LP1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550639970 | chr1:188955607-188955608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560780276 | chr1:188955668-188955669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374611038 | chr1:188955670-188955671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35638418 | chr1:188955686-188955687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115073348 | chr1:188955696-188955697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79542875 | chr1:188955727-188955728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141806643 | chr1:188955751-188955752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183552810 | chr1:188955754-188955755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540741070 | chr1:188955769-188955770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552426355 | chr1:188955790-188955791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs117107598 | chr1:188955798-188955799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537997718 | chr1:188955813-188955814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146183175 | chr1:188955815-188955816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574795517 | chr1:188955823-188955824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73059850 | chr1:188955828-188955829 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs553716628 | chr1:188955838-188955839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114352679 | chr1:188955863-188955864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12759467 | chr1:188955897-188955898 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs562987248 | chr1:188955906-188955907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138234729 | chr1:188955908-188955909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576587478 | chr1:188955918-188955919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542010237 | chr1:188955930-188955931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563223103 | chr1:188955934-188955935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530749778 | chr1:188955949-188955950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561059402 | chr1:188955951-188955952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529778909 | chr1:188955963-188955964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs369113630 | chr1:188955977-188955978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12733499 | chr1:188955985-188955986 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs560166677 | chr1:188956012-188956013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78978241 | chr1:188956013-188956014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528129081 | chr1:188956024-188956025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377590297 | chr1:188956071-188956072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111989611 | chr1:188956077-188956078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569019739 | chr1:188956084-188956085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111809665 | chr1:188956085-188956086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192691106 | chr1:188956120-188956121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183467054 | chr1:188956160-188956161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534014069 | chr1:188956165-188956166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs79562395 | chr1:188956262-188956263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150966702 | chr1:188956288-188956289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556817818 | chr1:188956303-188956304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576633324 | chr1:188956325-188956326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188195052 | chr1:188956372-188956373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191544878 | chr1:188956415-188956416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184078007 | chr1:188956425-188956426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139513874 | chr1:188956444-188956445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10801063 | chr1:188956465-188956466 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs73059852 | chr1:188956480-188956481 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs540138950 | chr1:188956501-188956502 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560229958 | chr1:188956506-188956507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:188955600-188956400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:188955800-188956400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr1:188955800-188956400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr1:188955800-188956600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr1:188956200-188956400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr1:188956200-188956600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr1:188956200-188956800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr1:188956400-188959200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr1:188956800-188961400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr1:188958800-188959400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr1:188959200-188960000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr1:188959400-188959600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr1:188959600-188961600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr1:188961400-188962600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr1:188961400-188963000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr1:188961600-188963000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr1:188962000-188962600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr1:188962000-188962600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr1:188962200-188962600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr1:188990000-188990800 | Enhancers | A549 | lung |
21 | chr1:188990800-188991200 | Flanking Active TSS | A549 | lung |
22 | chr1:188991200-188991800 | Enhancers | A549 | lung |
23 | chr1:188991800-188996400 | Weak transcription | A549 | lung |
24 | chr1:188996400-188996600 | Active TSS | A549 | lung |
25 | chr1:188996600-188996800 | Flanking Active TSS | A549 | lung |
26 | chr1:188996800-188997000 | Enhancers | A549 | lung |
27 | chr1:189008000-189008600 | Enhancers | Fetal Lung | lung |
28 | chr1:189015400-189015800 | Enhancers | Fetal Brain Female | brain |